Synthesis, Characterization, and In Vitro Drug Release Study of Methacrylate Diclofenac Conjugate as Macromolecular Prodrug

References

1. 1.↵
   1. Block J. H.,
   2. Beale J. M.

   Wilson & Gisvold's Textbook of Organic Medicinal & Pharmaceutical Chemistry, XI; Lippincott Williams & Wilkins: Baltimore, MD, 2004; p 753.
2. 2.↵
   1. Gairola N.,
   2. Nagpal D.,
   3. Dhaneshwar S. S.,
   4. Chaturvedi S. C.

   Synthesis, hydrolysis kinetics and pharmacodynamic profile of novel prodrugs of flurbiprofen. Indian J. Pharm. Sci. 2005, 67 (3), 369–373.

   OpenUrl
3. 3.↵
   1. Cross P. L.,
   2. Ashby D.,
   3. Harding G.,
   4. Hennessy E. M.,
   5. Letley L.,
   6. Parsons S.,
   7. Spencer A. E.,
   8. Underwood M.

   TOIB Study. Are topical or oral ibuprofen equally effective for the treatment of chronic knee pain presenting in primary care: a randomised controlled trial with patient preference study. BMC Musculoskelet Disord. 2005, 6, 55.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Cioli V.,
   2. Putzolu S.,
   3. Rossi V.,
   4. Carrandino C.

   The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol. Appl. Pharmacol. 1979, 50 (2), 283–289.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Otterness I. G.,
   2. Bliven M. L.,
   3. Lombardino J. M.

   Nonsteroidal Antiinflammatory Drugs; Interscience Publication: New York, 1985; p 111.
6. 6.↵
   1. Ghodeswar B. C.,
   2. Pophalikar R. N.,
   3. Bhojani M. R.,
   4. Nagpal D.,
   5. Dhaneshwar S. S.

   Synthesis and pharmacological evaluation of mutual prodrugs of some nonsteroidal anti-inflammatory drugs with glucosamine. Indian J. Pharm. Sci. 2004, 66 (6), 773–777.

   OpenUrl
7. 7.↵
   1. Bhosale A. V.,
   2. Agrawal G. P.,
   3. Mishra P.

   Hydrolysis kinetics studies of mutual prodrugs of ibuprofen. Indian J. Pharm. Sci. 2004, 66 (5), 626–630.

   OpenUrl
8. 8.↵
   1. Bhosale A. V.,
   2. Agrawal G. P.,
   3. Mishra P.

   Preparation and characterization of mutual prodrugs of ibuprofen. Indian J. Pharm. Sci. 2004, 66 (2), 158–163.

   OpenUrl
9. 9.↵
   1. Manon B.,
   2. Sharma P. D.

   Design, synthesis and evaluation of diclofenac-antioxidant mutual prodrugs as safer NSAIDs. Indian Journal of Chemistry. Sect. B: Organic Chemistry, Including Medical Chemistry 2009, 48 (9), 1279–1287.

   OpenUrl
10. 10.↵
    1. Mishra A.,
    2. Veerasamy R.,
    3. Jain P. K.,
    4. Dixit V. K.,
    5. Agrawal R. K.

    Synthesis, characterization and pharmacological evaluation of amide prodrugs of ketorolac. Eur. J. Med. Chem. 2008, 43 (11), 2464–2472.

    OpenUrlPubMed
11. 11.↵
    1. Gairola N.,
    2. Nagpal D.,
    3. Dhaneshwar S. S.,
    4. Dhaneshwar S. R.,
    5. Chaturvedi S. C.

    Synthesis, hydrolysis kinetics and pharmacodynamic profile of novel prodrugs of flurbiprofen. Indian J. Pharm. Sci. 2005, 67 (3), 369–373.

    OpenUrl
12. 12.↵
    1. Bansal A. K.,
    2. Khar R. K.,
    3. Dubey R.,
    4. Sharma A. K.

    Alkyl ester prodrugs for improved topical delivery of ibuprofen. Indian J. Exp. Biol. 2001, 39 (3), 280–283.

    OpenUrlPubMed
13. 13.↵
    1. Khan M. S.,
    2. Akhter M.

    Synthesis, pharmacological activity and hydrolytic behavior of glyceride prodrugs of ibuprofen. Eur. J. Med. Chem. 2005, 40 (4), 371–376.

    OpenUrlPubMed
14. 14.↵
    1. Jilani J. A.,
    2. Pillai G. K.,
    3. Salem M. S.,
    4. Najib N. M.

    Evaluation of hydroxyethyl esters of mefenamic acid and diclofenac as prodrugs. Drug Dev. Ind. Pharm. 1997, 23 (3), 319–323.

    OpenUrl
15. 15.↵
    1. Tammara V. K.,
    2. Narurkar M. M.,
    3. Crider A. M.,
    4. Khan M. A.

    Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation. J. Pharm. Sci. 1994, 83 (5), 644–648.

    OpenUrlPubMed
16. 16.↵
    1. Davaran S.,
    2. Rashidi M. R.,
    3. Hashemi M.

    Synthesis and hydrolytic behaviour of 2-mercaptoethyl ibuprofenate-polyethylene glycol conjugate as a novel transdermal prodrug. J. Pharm. Pharmacol. 2003, 55 (4), 513–517.

    OpenUrlPubMed
17. 17.↵
    1. Davaran S.,
    2. Rashidi M. R.,
    3. Hashemi M.,
    4. Hanaee J.,
    5. Hamidi A. A.

    Synthesis and hydrolytic behavior of ibuprofen prodrugs and their PEGylated derivatives. Drug Deliv. 2006, 13 (5), 383–387.

    OpenUrlPubMed
18. 18.↵
    1. Babazadeh M.

    Design, synthesis and in vitro evaluation of vinyl ether type polymeric prodrugs of ibuprofen, ketoprofen and naproxen. Int. J. Pharm. 2008, 356 (1–2), 167–173.

    OpenUrlPubMed
19. 19.↵
    1. Babazadeh M.

    Synthesis and study of controlled release of ibuprofen from the new acrylic type polymers. Int. J. Pharm. 2006, 316 (1–2), 68–73.

    OpenUrlPubMed
20. 20.↵
    1. Davaran S.,
    2. Hanaee J.,
    3. Khosravi A.

    Release of 5-amino salicylic acid from acrylic type polymeric prodrugs designed for colon-specific drug delivery. J. Controlled Release 1999, 58 (3), 279–287.

    OpenUrlPubMed
21. 21.↵
    1. Park K.

    Controlled Drug Delivery: Challenges and Strategies; ACS Professional Reference Book; American Chemical Society: Washington, DC, 1997; p 455.
22. 22.↵
    1. Giammona G.,
    2. Cavallaro G.,
    3. Fontana G.,
    4. Pitarresi G.,
    5. Carlisi B.

    Coupling of the antiviral agent zidovudine to polyaspartamide and in vitro drug release studies. J. Controlled Release 1998, 54 (3), 321–331.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Montheard J. P.,
    2. Chatzopoulos M.,
    3. Chappard D.

    2-hydroxyethyl methacrylate (HEMA): chemical properties and applications in biomedical fields. J. Macromol. Sci. Macromol. Rev. 1992, 32, 16.

    OpenUrl
24. 24.↵
    1. Mabilleau G.,
    2. Stancu I. C.,
    3. Honore T.,
    4. Legeay G.,
    5. Cincu C.,
    6. Basle M. F.,
    7. Chappard D.

    Effects of the chain length of cross-linkers on poly(2-hydroxyethyl methacrylate) (pHEMA) swelling and biomechanical properties. J. Biomed. Mater. Res. A 2006, 77, 35.

    OpenUrlPubMed
25. 25.↵
    United States Pharmacopoeia 28, National Formulary 23, Asian ed.; United States Pharmacopeial Convention, Inc.: Rockville, MD, 2005; p 2412.
26. 26.↵
    1. Washington N.,
    2. Washington C.,
    3. Wilson C. G.

    Physiological Pharmaceutics: Barriers to Drug Absorption, 2nd ed.; Taylor and Francis, Inc.: New York, 2000; pp 95–97.